Ratan Capital Management LP Intellia Therapeutics, Inc. Transaction History

Ratan Capital Management LP

  • $556 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$58.27 - $118.99 $1.75 Million - $3.57 Million
-30,000 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$100.76 - $138.36 $5.27 Million - $7.24 Million
-52,352 Reduced 63.57%
30,000 $3.55 Million
Q3 2021

Nov 15, 2021
BUY
$132.37 - $176.78 $4.28 Million - $5.72 Million
32,352 Added 64.7%
82,352 $11 Million
Q2 2021

Aug 16, 2021
BUY
$60.88 - $161.91 $3.04 Million - $8.1 Million
50,000 New
50,000 $8.1 Million

Others Institutions Holding NTLA

# of Institutions
336
Shares Held
96.1M
Call Options Held
1.06M
Put Options Held
863K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $931M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Ratan Capital Management LP Portfolio

Follow Ratan Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ratan Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Ratan Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email